December 8, 2022
The Cardiovascular Research Methods Centre at the University of Ottawa Heart Institute, led by George Wells, PhD, is the coordinating centre for a randomized controlled trial recently published in one of the world’s leading medical journals, the New England Journal of Medicine.
Wells et al conclude catheter cryoablation, more so than antiarrhythmic drug therapy, is associated with sustained, positive effects on AF progression in patients with paroxysmal atrial fibrillation.
Read: Progression of Atrial Fibrillation after Cryoablation or Drug Therapy.
Media contact
Leigh Morris
Communications Officer
University of Ottawa Heart Institute
613-316-6409 (cell)
lmorris@ottawaheart.ca